TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Ebba Biotech AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,851
|
1,487
|
1,162 |
Financial expenses |
20
|
16
|
23 |
Earnings before taxes |
-1,804
|
-3,399
|
-2,764 |
EBITDA |
-1,724
|
-3,327
|
-2,681 |
Total assets |
1,224
|
1,797
|
1,528 |
Current assets |
1,077
|
1,617
|
1,287 |
Current liabilities |
441
|
810
|
242 |
Equity capital |
283
|
587
|
486 |
- share capital |
63
![]() |
63
![]() |
63 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
23.1%
|
32.7%
|
31.8% |
Turnover per employee |
463
|
372
|
387 |
Profit as a percentage of turnover |
-97.5%
|
-228.6%
|
-237.9% |
Return on assets (ROA) |
-145.8%
|
-188.3%
|
-179.4% |
Current ratio |
244.2%
|
199.6%
|
531.8% |
Return on equity (ROE) |
-637.5%
|
-579.0%
|
-568.7% |
Change turnover |
364
|
325
|
606 |
Change turnover % |
24%
|
28%
|
109% |
Chg. No. of employees |
0
|
1
|
2 |
Chg. No. of employees % |
0%
|
33%
|
200% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.